223 related articles for article (PubMed ID: 22265270)
1. Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials.
Meng H; Sun Y; Lu J; Fu S; Meng Z; Scott M; Li Q
J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):849-56. PubMed ID: 22265270
[TBL] [Abstract][Full Text] [Related]
2. Exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approach.
Dushianthan A; Cusack R; Grocott M; Postle A
J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):e50. PubMed ID: 22520116
[No Abstract] [Full Text] [Related]
3. Pediatric calfactant in acute respiratory distress syndrome trial.
Willson DF; Thomas NJ; Tamburro R; Truemper E; Truwit J; Conaway M; Traul C; Egan EE;
Pediatr Crit Care Med; 2013 Sep; 14(7):657-65. PubMed ID: 23846250
[TBL] [Abstract][Full Text] [Related]
4. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.
Davidson WJ; Dorscheid D; Spragg R; Schulzer M; Mak E; Ayas NT
Crit Care; 2006; 10(2):R41. PubMed ID: 16542488
[TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.
Gebistorf F; Karam O; Wetterslev J; Afshari A
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD002787. PubMed ID: 27347773
[TBL] [Abstract][Full Text] [Related]
6. Lung protective ventilation strategy for the acute respiratory distress syndrome.
Petrucci N; De Feo C
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003844. PubMed ID: 23450544
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?
Dushianthan A; Cusack R; Goss V; Postle AD; Grocott MP
Crit Care; 2012 Nov; 16(6):238. PubMed ID: 23171712
[TBL] [Abstract][Full Text] [Related]
8. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
9. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
10. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
Kesecioglu J; Haitsma JJ
Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
[TBL] [Abstract][Full Text] [Related]
11. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
12. Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation.
Hodgson C; Goligher EC; Young ME; Keating JL; Holland AE; Romero L; Bradley SJ; Tuxen D
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006667. PubMed ID: 27855477
[TBL] [Abstract][Full Text] [Related]
13. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Willson D; Notter RH
Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
[TBL] [Abstract][Full Text] [Related]
14. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
Meng SS; Chang W; Lu ZH; Xie JF; Qiu HB; Yang Y; Guo FM
BMC Pulm Med; 2019 Jan; 19(1):9. PubMed ID: 30626363
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis.
Zhang R; Wang X; Li S; Yan J
BMC Pulm Med; 2020 Aug; 20(1):210. PubMed ID: 32762672
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography assessment of exogenous surfactant-induced lung reaeration in patients with acute lung injury.
Lu Q; Zhang M; Girardi C; Bouhemad B; Kesecioglu J; Rouby JJ
Crit Care; 2010; 14(4):R135. PubMed ID: 20633284
[TBL] [Abstract][Full Text] [Related]
17. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome.
Galvin IM; Steel A; Pinto R; Ferguson ND; Davies MW
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003707. PubMed ID: 23881653
[TBL] [Abstract][Full Text] [Related]
18. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome.
Sud S; Sud M; Friedrich JO; Wunsch H; Meade MO; Ferguson ND; Adhikari NK
Cochrane Database Syst Rev; 2013 Feb; (2):CD004085. PubMed ID: 23450549
[TBL] [Abstract][Full Text] [Related]
19. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome.
Kaushal A; McDonnell CG; Davies MW
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003845. PubMed ID: 23450545
[TBL] [Abstract][Full Text] [Related]
20. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.
Dushianthan A; Cusack R; Burgess VA; Grocott MP; Calder PC
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012041. PubMed ID: 30677127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]